a month ago
ABVX
AnalystsJulian HarrisonJulian Harrison's Stock Forecasts
AnalystsJulian Harrison
Sectors:
Industries:
Analyst Ranking
Top 1%
#52 out of 5334 analysts
Average Return
+54.06%
Win Rate
67%102 out of 152
Risk vs Reward
Poor
Good
Julian Harrison's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Spyre Therapeutics IncSYRE | +589.14% | $14.82 | $102.13 | 2025-09-16 - 2026-07-24 | Strong Buy |
Climb Bio IncCLYM | +558.46% | $1.95 | $12.84 | 2025-10-16 - 2026-07-24 | Strong Buy |
Climb Bio IncCLYM | +538.81% | $2.01 | $12.84 | 2025-09-30 - 2026-07-24 | Strong Buy |
Oruka Therapeutics IncORKA | +468.54% | $16.21 | $92.16 | 2025-09-17 - 2026-07-24 | Strong Buy |
Climb Bio IncCLYM | +453.45% | $2.32 | $12.84 | 2025-09-22 - 2026-07-24 | Strong Buy |
Julian Harrison Analyst Color
Get additional color on Julian Harrison's coverage of popular stocks
a month ago
SYRE
a month ago
CLYM
2 months ago
RZLT
3 months ago
INVA
3 months ago
CLYM
3 months ago
AVTX
3 months ago
ORKA
3 months ago
SYRE
3 months ago
ORKA
4 months ago
JBIO
6 months ago
NKTR
7 months ago
ARDX
7 months ago
ABVX
7 months ago
APGE
7 months ago
APGE
8 months ago
TBPH
8 months ago
CGEM
8 months ago
RNAC
8 months ago
ORKA
10 months ago
ABVX
10 months ago
CLYM
10 months ago
MAZE
a year ago
TBPH
2 years ago
OTLK
Julian Harrison's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Oruka Therapeutics IncORKA | 9 | Strong Buy | $151.00 | +63.85% | Reiterates | 13 days ago |
Tvardi Therapeutics IncTVRD | 3 | Strong Buy | $15.00 | +497.61% | Reiterates | 19 days ago |
Abivax SaABVX | 8 | Strong Buy | $175.00 | +39.22% | Maintains | a month ago |
Innoviva IncINVA | 5 | Strong Buy | $42.00 | +95.90% | Maintains | a month ago |
Liquidia CorpLQDA | 9 | Strong Buy | $109.00 | +26.42% | Maintains | a month ago |
Avalo Therapeutics IncAVTX | 6 | Strong Buy | $58.00 | +214.53% | Reiterates | a month ago |
Spyre Therapeutics IncSYRE | 9 | Strong Buy | $112.00 | +9.66% | Maintains | a month ago |
Climb Bio IncCLYM | 7 | Strong Buy | $20.00 | +55.76% | Maintains | a month ago |
Cartesian Therapeutics IncRNAC | 3 | Strong Buy | $44.00 | +458.38% | Reiterates | 2 months ago |
Moonlake ImmunotherapeuticsMLTX | 7 | Strong Buy | $30.00 | +57.73% | Reiterates | 2 months ago |
Rezolute IncRZLT | 6 | Strong Buy | $6.00 | +20.24% | Maintains | 2 months ago |
Jade Biosciences IncJBIO | 7 | Strong Buy | $74.00 | +268.53% | Maintains | 2 months ago |
Apogee Therapeutics IncAPGE | 7 | Strong Buy | $137.00 | +2.03% | Reiterates | 2 months ago |
Cullinan Therapeutics IncCGEM | 5 | Strong Buy | $38.00 | +122.22% | Reiterates | 2 months ago |
Mereo Biopharma Group PLCMREO | 4 | Strong Buy | $1.00 | +247.22% | Reiterates | 2 months ago |
Nektar TherapeuticsNKTR | 5 | Strong Buy | $178.00 | +151.68% | Maintains | 3 months ago |
Akebia Therapeutics IncAKBA | 5 | Strong Buy | $4.00 | +227.87% | Reiterates | 4 months ago |
Connect Biopharma Holdings LtdCNTB | 4 | Strong Buy | $10.00 | +367.29% | Reiterates | 4 months ago |
Maze Therapeutics IncMAZE | 6 | Strong Buy | $46.00 | +66.18% | Reiterates | 4 months ago |
Theravance Biopharma IncTBPH | 6 | Strong Buy | $21.00 | +24.56% | Reiterates | 4 months ago |
Ardelyx IncARDX | 3 | Strong Buy | $17.00 | +237.97% | Reiterates | 5 months ago |
Viridian Therapeutics IncVRDN | 4 | Strong Buy | $61.00 | +216.55% | Reiterates | 9 months ago |
Protagonist Therapeutics IncPTGX | 3 | Strong Buy | $82.00 | -39.75% | Reiterates | 9 months ago |
Outlook Therapeutics IncOTLK | 4 | Strong Buy | $9.00 | N/A | Maintains | 2 years ago |
Aclaris Therapeutics IncACRS | 3 | Strong Buy | $8.00 | N/A | Upgrades | 2 years ago |
Vyne Therapeutics IncVYNE | 1 | Strong Buy | $8.00 | N/A | Initiates Coverage On | 2 years ago |
Anaptysbio IncANAB | 1 | Strong Buy | $55.00 | N/A | Initiates Coverage On | 2 years ago |
Matinas Biopharma Holdings IncMTNB | 1 | Strong Buy | $150.00 | N/A | Reinstates | 3 years ago |
Cymabay Therapeutics IncCBAY | 7 | Strong Buy | $24.00 | N/A | Maintains | 3 years ago |
Keros Therapeutics IncKROS | 2 | Strong Buy | $105.00 | N/A | Maintains | 4 years ago |
Prometheus Biosciences IncRXDX | 3 | Strong Buy | $181.00 | N/A | Maintains | 4 years ago |
Biora Therapeutics IncBIOR | 1 | Strong Buy | $4.00 | N/A | Assumes | 4 years ago |
United Therapeutics CorpUTHR | 1 | Hold | N/A | N/A | Initiates Coverage On | 4 years ago |
Morphic Holding IncMORF | 1 | Strong Buy | $64.00 | N/A | Initiates Coverage On | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.